Apotex-Ivax generic Paxil ruling
D.C. federal court upholds lower judge's ruling rejecting Apotex' request to intervene in an Ivax-GSK covenant over generic Paxil (paroxetine). Apotex claimed an Ivax-GSK agreement would trigger the exclusivity period for paroxetine through a court dismissal. Apotex' case was given a skeptical hearing a day before the court ruling (1"The Pink Sheet" Aug. 11, 2003, p. 17)...
You may also be interested in...
Ivax is one of at least four drug companies that will share exclusivity for generic versions of GlaxoSmithKline's Paxil (paroxetine)
A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.